Accounts Receivable	6 Months Ended
	Jun. 30, 2021
Receivables [Abstract]
Accounts Receivable	Accounts Receivable    As of June 30, 2021 and December 31, 2020, the Company had accounts receivable of $9.7 million and $8.9 million respectively, which primarily relates to royalty revenue from sales of NARCAN®.